Nerve grafting for peripheral nerve injuries with extended defect sizesNerventransplantate für periphere Nervenverletzungen ausgedehnterer Defektgrößen

被引:0
|
作者
Tim Kornfeld
Peter M. Vogt
Christine Radtke
机构
[1] Hannover Medical School,Department of Plastic, Aesthetic, Hand and Reconstructive Surgery
[2] Medical University of Vienna,Department of Plastic and Reconstructive Surgery
来源
关键词
FDA; Cell transplantation; Artificial graft; Autograft; Allograft; FDA; Zelltransplantation; Kunsttransplantat; Autotransplantat; Allogenes Transplantat;
D O I
暂无
中图分类号
学科分类号
摘要
Artificial and non-artificial nerve grafts are the gold standard in peripheral nerve reconstruction in cases with extensive loss of nerve tissue, particularly where a direct end-to-end suture or an autologous nerve graft is inauspicious. Different materials are marketed and approved by the US Food and Drug Administration (FDA) for peripheral nerve graft reconstruction. The most frequently used materials are collagen and poly(DL-lactide-ε-caprolactone). Only one human nerve allograft is listed for peripheral nerve reconstruction by the FDA. All marketed nerve grafts are able to demonstrate sufficient nerve regeneration over small distances not exceeding 3.0 cm. A key question in the field is whether nerve reconstruction on large defect lengths extending 4.0 cm or more is possible. This review gives a summary of current clinical and experimental approaches in peripheral nerve surgery using artificial and non-artificial nerve grafts in short and long distance nerve defects. Strategies to extend nerve graft lengths for long nerve defects, such as enhancing axonal regeneration, include the additional application of Schwann cells, mesenchymal stem cells or supporting co-factors like growth factors on defect sizes between 4.0 and 8.0 cm.
引用
收藏
页码:240 / 251
页数:11
相关论文
共 2 条